CHAMOMILLA RECOMMENDED USE AS TREATMENT AND PREVENTION OF FLEBITE IN PATIENTS WITH CANCER: LITERATURE REVIEW

Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2018, Vol 7, Issue 9

Abstract

The occurrence of cancer has been increasing annually, representing the second cause of death in Brazil and world. According to World Health Organization, cancer is an important public health issue in both developed and developing countries, where it is expected in next decades an impact on the population about 80% of more than 20 million new cases at 2025. Chemotherapy is one of the treatment modalities, whose eliminate malignant cells, acting in a systemic way, and the drugs act indiscriminately in the patient's cells, producing very unpleasant and adverse effects. Phlebitis may be considered a temporary or permanent limiting factor for the continuity of treatment in patients with cancer. Depending on extent of inflammatory process at the venipuncture site, the vascular endothelium suffers irreversible lesions, such as phlebosclerosis, and then this vein is impossible to be used for new punctures. The prevention of phlebitis, the control of evolution after occurrence and the reversal of the inflammatory signs are necessary, especially in patients who have a highly sensitized veins. Phytotherapics have been used as an alternative way to treat phlebitis. Chamomilla recutita has been used in ointment, gels or compresses due to potential anti- inflammatory effect. The present literature review aimed to collect data on the treatment of phlebitis with Chamomilla recutita in cancer patients, and suggests and to suggest its use.

Authors and Affiliations

Ana Laura Remédio Zeni Beretta

Keywords

Related Articles

COMPARISON BETWEEN PHENOTYPIC AND GENOTYPIC METHODS FOR THE DETECTION OF METALLO BETA LACTAMASES PRODUCING PSEUDOMONAS AERUGINOSA

Background: Pseudomonas aeruginosa is a frequent nosocomial pathogen that causes severe diseases in many settings. Carbapenem resistance may be conferred through various mechanisms, including the expression of carbapenem...

EFFECT OF CREMOPHOR RH 40 ON DISSOLUTION RATE OF ATORVASTATIN TABLET

Atorvastatin is one of the active substance with anti hypercholestrol activity from statin group. Atorvastatin and its active metabolite that structurally similar with HMG-CoA compete to bind with active site of HMG-CoA...

APPLICATION OF THE METHOD OF THERMAL-SECURITY SURFACE-IONIZATION SPECTROSCOPY IN ANALYSIS OF ALKALOIDS OF CONIUM MACULATUM

Cicuta maculata is a species of flowering plants in the carrot family, known by several common names, including spotted water hemlock, spotted parsley, spotted cowboy and the root of suicide in the Iroquois. In this arti...

PREVALENCE AND POSSIBLE RISK FACTORS ASSOCIATED WITH OVERWEIGHT AND OBESITY AMONG ADULTS IN MAYO AREA IN KHARTOUM STATE-SUDAN

This is a descriptive cross - sectional community based study, was carried out among adults in Mayo area in Khartoum State - Sudan, aims to estimate the prevalence of and to identify the possible risk factors associated...

A REVIEW ON PROTON PUMP INHIBITORS INDUCED DISEASES

The proton pump inhibitors are most effective and mostly prescribed drugs in the clinics now-a-days and also used during multi drug therapy. They have a greater degree and longer duration action when compared to H2-recep...

Download PDF file
  • EP ID EP627987
  • DOI -
  • Views 145
  • Downloads 0

How To Cite

Ana Laura Remédio Zeni Beretta (2018). CHAMOMILLA RECOMMENDED USE AS TREATMENT AND PREVENTION OF FLEBITE IN PATIENTS WITH CANCER: LITERATURE REVIEW. WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE, 7(9), 220-227. https://europub.co.uk/articles/-A-627987